These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

971 related articles for article (PubMed ID: 16502129)

  • 1. Vascular calcification in chronic kidney disease.
    Jono S; Shioi A; Ikari Y; Nishizawa Y
    J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperphosphatemia and vascular calcification in end-stage renal disease.
    Nishizawa Y; Jono S; Ishimura E; Shioi A
    J Ren Nutr; 2005 Jan; 15(1):178-82. PubMed ID: 15648030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).
    Moe SM; Reslerova M; Ketteler M; O'neill K; Duan D; Koczman J; Westenfeld R; Jahnen-Dechent W; Chen NX
    Kidney Int; 2005 Jun; 67(6):2295-304. PubMed ID: 15882271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current concepts of vascular calcification].
    Kozaki K
    Nihon Ronen Igakkai Zasshi; 2005 Nov; 42(6):659-61. PubMed ID: 16408509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcification and inorganic phosphate.
    Giachelli CM; Jono S; Shioi A; Nishizawa Y; Mori K; Morii H
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S34-7. PubMed ID: 11576919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of vascular calcification in chronic kidney disease.
    Moe SM; Chen NX
    Circ Res; 2004 Sep; 95(6):560-7. PubMed ID: 15375022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate regulation of vascular smooth muscle cell calcification.
    Jono S; McKee MD; Murry CE; Shioi A; Nishizawa Y; Mori K; Morii H; Giachelli CM
    Circ Res; 2000 Sep; 87(7):E10-7. PubMed ID: 11009570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.
    Steitz SA; Speer MY; Curinga G; Yang HY; Haynes P; Aebersold R; Schinke T; Karsenty G; Giachelli CM
    Circ Res; 2001 Dec; 89(12):1147-54. PubMed ID: 11739279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular calcification: mechanisms and clinical ramifications.
    Abedin M; Tintut Y; Demer LL
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1161-70. PubMed ID: 15155384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of arterial calcification corrects the low bone mass phenotype in MGP-deficient mice.
    Marulanda J; Gao C; Roman H; Henderson JE; Murshed M
    Bone; 2013 Dec; 57(2):499-508. PubMed ID: 23994172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.
    Shioi A; Nishizawa Y
    J Ren Nutr; 2009 Jan; 19(1):78-81. PubMed ID: 19121777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein.
    Proudfoot D; Shanahan CM
    Nephrology (Carlton); 2006 Oct; 11(5):455-61. PubMed ID: 17014561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system.
    Viegas CS; Rafael MS; Enriquez JL; Teixeira A; Vitorino R; Luís IM; Costa RM; Santos S; Cavaco S; Neves J; Macedo AL; Willems BA; Vermeer C; Simes DC
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):399-408. PubMed ID: 25538207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
    Mathew S; Davies M; Lund R; Saab G; Hruska KA
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors of atherosclerosis in end-stage renal disease patients].
    Jono S
    Clin Calcium; 2004 Jan; 14(1):21-6. PubMed ID: 15576949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibulin-3 Attenuates Phosphate-Induced Vascular Smooth Muscle Cell Calcification by Inhibition of Oxidative Stress.
    Luong TTD; Schelski N; Boehme B; Makridakis M; Vlahou A; Lang F; Pieske B; Alesutan I; Voelkl J
    Cell Physiol Biochem; 2018; 46(4):1305-1316. PubMed ID: 29689558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification.
    Sato Y; Nakamura R; Satoh M; Fujishita K; Mori S; Ishida S; Yamaguchi T; Inoue K; Nagao T; Ohno Y
    Circ Res; 2005 Sep; 97(6):550-7. PubMed ID: 16100044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.
    Suliman ME; García-López E; Anderstam B; Lindholm B; Stenvinkel P
    Adv Clin Chem; 2008; 46():217-62. PubMed ID: 19004191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Role of vascular smooth muscle cells in vascular calcification].
    Kurabayashi M
    Clin Calcium; 2015 May; 25(5):661-9. PubMed ID: 25926569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.